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Abstract.  We have tested the effects of an mAb 
directed against the protein core of the extracellular 
domain of the human EGF receptor (mAbl08), on the 
binding of EGF, and on the early responses of cells to 
EGF presentation.  We used NIH 3T3 cells devoid of 
murine EGF receptor, transfected with a eDNA encod- 
ing the full-length human EGF receptor gene, and 
fully responsive to EGE  The binding to saturation of 
mAbl08 to the surface of these cells at 4°C and  at 
other temperatures  specifically reduced high-affinity 
binding of EGF, but did not change the dissociation 
constant or the estimated number of binding  sites for 
low-affinity binding of EGE  The kinetics of EGF 
binding to the transfected cells were measured to de- 
termine the effects of the mAb on the initial rate of 
EGF binding at 37°C.  Interestingly,  high-affinity EGF 
receptor bound EGF with an intrinsic  on-rate constant 
40-fold higher (9.8  x  106 M-~-s  -~) than did low-affinity 
receptor (2.5  ×  105 M-Ls-~), whereas the off-rate con- 
stants,  measured at 4°C were similar.  Cells treated 
with the mAb or with phorbol myristate acetate dis- 
played single on-rate constants similar to that for the 
low-affinity receptors. 
At low doses of EGF ranging  from 0.4 to  1.2 nM, 
pretreatment of cells with mAbl08 inhibited by 
50-100%  all of the early responses tested, including 
stimulation of tyrosine-specific phosphorylation of the 
EGF receptor, turnover of phosphatidyl inositol, eleva- 
tion of cytoplasmic pH, and release of Ca  2+ from in- 
tracellular  stores.  At saturating  doses of EGF (20 nM) 
the inhibition of these early responses by prebinding 
of mAbl08 was overcome. On the basis of these 
results,  we propose that the high-affinity EGF recep- 
tors are necessary for EGF receptor signal trans- 
duction. 
PIDERMAL growth factor (EGF) is a polypeptide hor- 
mone that  is mitogenic  for a variety  of cell types, 
including fibroblasts and epithelial cells (reviewed in 
Carpenter and Cohen, 1979, and Schlessinger  et al.,  1983). 
EGF exerts its effects through  the EGF receptor (EGF-R), * 
a glycoprotein that resides in the plasma membrane,  binds 
and internalizes EGF, and contains within its cytoplasmic do- 
main a tyrosine-specific protein  kinase activity. The kinase 
domain is homologous to a family of membrane-bound tyro- 
sine kinase enzymes that are involved in normal growth con- 
trol or have been implicated in oncogenic growth stimulation 
(Downward et al.,  1984, Hunter and Cooper, 1985, Yarden 
and Ullrich,  1988). The binding of EGF to the EGF-R stimu- 
lates a series of rapid responses, including  phosphorylation 
of  tyrosine residues within the EGF-R itself and within many 
1.  Abbreviations  used in  this  paper:  BCECE bis(carboxyethyl)carboxy- 
fluorescein;  EGF-R,  epidermal  growth  factor-receptor;  HNTG  solution, 
20 mM Hepes, pH 7.5, 150 mM NaCI, 0.1% Triton X-100, 10% glycerol; 
PMA, phorbol  myristate acetate. 
other cellular  proteins,  hydrolysis of phosphatidyl  inositol, 
release of Ca  ~+ from intracellular  stores and  in some cell 
types the influx of extracellular  Ca  2÷, elevation of cytoplas- 
mic pH, and morphological  changes.  After 10-12 h in the 
continuous presence of EGF quiescent target cells are com- 
mitted to synthesize DNA and to divide.  The kinase activity 
appears a necessary part of the signal transduetion  process, 
because its inactivation  by site directed mutagenesis  results 
in an EGF-R that is normal in EGF binding and internaliza- 
tion, but that is completely dysfunctional  in signal transduc- 
tion and normal receptor routing (Livneh et al., 1986; Chen 
et al.,  1987; Honegger et al.,  1987a,b;  Moolenaar et al., 
1988). The mechanism  whereby EGF binding activates  the 
EGF-R tyrosine kinase  and elicits early and late responses 
remains  unresolved. 
One question  relating  to EGF-induced EGF-R activation 
is the mechanism  and role of high-  and  low-affinity EGF 
binding  (discussed  in  Carpenter,  1987, and  Schlessinger, 
1988).  The  differential  binding  characteristic  of EGF  is 
based on a curvilinear Scatchard plot (Scatchard,  1949) for 
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of receptor, with different affinities for EGF. WhetherEGF-R 
affinity is related to functionality (with respect to kinase ac- 
tivity or signal transduction) remains an open question. In 
this study, we investigate the action of two mAbs directed 
against the extracellular domain of the EGF-R and use them 
to probe the nature of EGF-R activation. We show that one 
antibody, mAb96, is an antagonist, that is, it competes with 
EGF for binding to the EGF-R, fails to stimulate any cell re- 
sponses by itself, and blocks EGF-induced cell responses 
(presumably by interfering with EGF binding). The other, 
mAbl08,  does not compete with EGF for binding to the 
EGF-R.  However,  mAbl08  has  been  shown  to  slow  the 
growth of two human tumor cell lines in culture and in nude 
mice (Aboud-Pirak et al., 1988, 1989). We demonstrate that 
although mAbl08 does not affect the binding of EGF at satu- 
ration, the antibody specifically inhibits high-affinity bind- 
ing of EGE Along with this reduction in high-affinity bind- 
ing, we show that mAbl08 inhibits several early responses 
to low, physiological doses but not to high doses of EGF. We 
suggest that high affinity receptors are necessary for EGF-R 
signal transduction. 
The early responses were measured rapidly at physiologi- 
cal temperatures, while the Scatchard analyses were mea- 
sured over a much longer time course at 4°C. Further, if the 
on-rates  of EGF binding are  the  same  for high and low 
affinity  binding, the amount of EGF bound quickly would be 
expected to be little affected by mAbl08, as the low-affinity 
sites so much outnumber the high-affinity  sites. We therefore 
will report on the kinetics of EGF binding as probed at physi- 
ological temperature,  and as affected by mAbl08  and by 
phorbol ester.  We show that it is an elevation in on-rate of 
EGF binding that is  responsible  for high-affinity binding 
rather than a reduction in off-rate, and that mAbl08 and the 
other treatments specifically reduced the high affinity on- 
rate, resulting in a twofold reduction in the amount of EGF 
bound quickly at low  EGF concentrations at  37°C.  Thus 
high-affinity  EGF binding can be demonstrated with kinetics 
measurements and is inhibited by mAbl08 at 37°C, directly 
correlating with the inhibition by mAbl08 of high affinity 
equilibrium binding and of early cell responses to low doses 
of EGE 
Materials and Methods 
Cell Culture 
Mouse myeloma and hybridoma cell lines were grown at 370C in DME con- 
taming 1 mM sodium pyruvate, 2 mM glutamine, and 10% FCS. The other 
cell lines (HER14, CH71, A431, Swiss 3T3) were grown in DME containing 
10% FCS. HER14 cells (Honegger et al., 1987a) are NIH 3T3 cells (clone 
2.2 lacking endogenous EGF-R) transfected with a plasmid beating the hu- 
man EGF-R full-length eDNA. The cloned transfectants express ~,500,000 
human EGF-Rs per cell, which appear fully functional in EGF binding, in- 
ternalization,  signal transduction, and stimulation of mitogenesis. 
Preparation of mAbs Directed against the 
Extracellular Domain of the EGF-R 
We have produced mAbs directed against the extracellular domain of  the hu- 
man EGF-R by immunizing female Balh/c mice with CH71  cells (Livneh 
et al., 1986). These cells are CHO cells that were transfected  with a plasmid 
hearing a eDNA construct of  the human EGF receptor truncated in the intra- 
cellular domain. They express a large number of EGF-R at their surface 
(>lO~/cell) as do A431 cells, but their EGF receptor molecules do not bear 
the highly antigenic blood group A-related carbohydrates of  A431 cell mem- 
brane proteins. Spleen cells of  two immunized mice were fused with NSO-1 
myeloma cells using a modified technique of Kohler and Milstein (1975). 
The hybridomas secreting mAbs against the EGF-receptor were selected for 
their ability to bind to either A431 or HERI4 cells. NIH  3T3-2.2  cells, 
which express no measurable EGF-R, were used as a negative control. The 
selected hybridomas were cloned and then injected into mice to produce as- 
cites fluid. After ammonium sulfate precipitation of the ascites fluid, two 
antibodies were purified: mAb96, (IgM) by gel filtration on Sepbacryl $300 
(Pharmacia Fine Chemicals, Piscataway,  NJ) column, and mAbl08 (IgG2a) 
by affinity on a protein A-Sepharuse column. 
Binding Experiments 
HER14 cells were grown in DME with 10% heat-inactivated FCS (Gibco 
Laboratories) to confluence on 24-well plates (Costar Corp., Cambridge, 
MA) coated with human fibronectin. Cells were washed twice with binding 
buffer (DME with 0.2% BSA and 20 mM Hepes, pH 7.4),  and incubated 
in 0.5 ml binding buffer with radioiodinated EGF (chloramine T method) 
or with radioiodinated mAbl08 (Iodogen method) added at the desired con- 
centrations at 4°C for 90 rain. For both 125I-EGF and 12q-mAbl08, rates 
of binding were tested, and at all concentrations used for our Scatchard 
curves binding had reached equilibrium by 90 rain (data not shown). After 
incubations, cells were washed three times with binding buffer and then 
lysed and the protein was dissolved with 0.5 ml of 0.2 M NaOH. This was 
collected and counted in a gamma counter. Counts for each sample were 
automatically recorded and stored on a microVAX computer, and data were 
fitted with a  nonlinear least squares algorithm for the Michealis-Menten 
binding equation assuming one or two binding populations, and plotted in 
Scatcbard format by the computer. 
psS]Cysteine Labeling of CeUs and 
Immunoprecipitation of  EGF-R 
Cells at 80% confluence in 10-cm tissue-culture dishes were washed with 
cysteine-free DME and grown overnight in cysteine-free DME containing 
10% FCS and 50 pCi/ml of [35Slcysteine (New England Nuclear, Boston, 
MA).  Cells  expressing  the  human  EGF-R  (HERI4),  chicken  EGF-R 
(CKI09) (Lax et al., 1988) and mouse EGF-R (Swiss 3T3) were used. The 
cells were washed three times with PBS and scraped into 0.5 ml of lysis 
buffer (20 mM Hepes, pH 7.5, 150 mM NaCI, 10% glycerol, 1% Triton X- 
100,  1.5 mM MgCI2,  1 mM EDTA,  1/~g/ml aprotinin, 1/~g,/ml leupeptin, 
1 mM PMSF) and incubated for 15 min on ice. The lysates were spun for 
15 min in an Eppendorf  centrifuge at 4°C. 3 nag of  protein A-Sepharose per 
sample were swollen and washed with 20 mM Hepes, pH 7.5,  and then 
mixed for 30 min at room temperature with goat anti-mouse antibody. After 
washing three times with 20 raM Hepes, pH 7.5, the protein A-Sepharose- 
goat anti-mouse antibody complex was further incubated with the different 
primary antibodies for another 30 min at room temperature and washed 
three times with HNTG buffer (20 mM Hepes, pH 7.5, 150 mM NaCl, 0.1% 
Triton X-100, 10% glycerol). The protein A-Sepharose/antibody complexes 
were then incubated with the respective labeled cell lysates for 60 rain in 
HNTG at 4°C, washed twice with 50 mM Hepes pH 8.0, 0.2 % Triton X-100, 
500 mM NaCl, and 5 mM EGTA, twice with 50 mM Hepes, pH 8.0, 0.1% 
Triton X-100, 0.1% SDS,  150 mM NaC1, 5 mM EGTA and twice with 10 
mM Tris-HCl, pH 8.0, 0.1%  Triton X-100.  Laemmli's sample buffer was 
added to the washed immunoprecipitates which were then boiled for 4 rain 
and separated on an SDS-polyacrylamide gel (7 %). Autoradiograms of the 
dried gels were made on Kodak X-Omat paper (Eastman Kodak Co., Roch- 
ester, NY). 
Phosphorylation of  EGF-R in Living Cells 
HER14 cells were grown to confluence in 35-mm culture dishes coated with 
fibronectin. Cells were washed once with binding buffer and incubated at 
4oC for 90 rain with or without mAb solutions in binding buffer. The plates 
were then placed in a water bath at 37°C and different  concentrations of  EGF 
were added to the cells for 2 min. The buffer was removed and cells were 
scraped off the plates with 0.5 ml of Laemmli's sample buffer, boiled for 
5 min, and sonicated for  10 s. Aliquots of each sample were run on two 
different SDS-polyacrylamide gels (7%) and each gel was transferred to 
nitrocellulose paper. One paper was immunoblotted with RK2 (K_ris et al., 
1985), an anti-EGF-R antibody (Fig. 5 C) and the other with an anti-phos- 
photyrosine-specific pelyclonal rabbit antibody (Fig.  5, A  and B).  Blots 
were then labeled with radioiodinated Protein A (New England Nuclear). 
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Cross-Inhibition of  Ligand Binding 
HERI4 cells at confluence in 24-well plates were washed with binding buffer 
and were incubated for 90 rain at 4°C with saturating concentrations of the 
mAbs or EGF.  At that time either radioiodinated mAb96, or mAbl08, or 
EGF was added at saturating concentrations (in the continued presence of 
unlabeled ligand), and the cells were incubated for another 90 min at 4°C 
and then washed three times with cold PBS. The radioactivity associated 
with the cells was counted in a  gamma counter. 
lntraceUular Free Calcium Measurements, Reporting 
Calcium Released from Intracellular Stores 
lntracellular  free Ca  2+  concentrations were  measured by fura-2 fluores- 
cence in a  spectrofluorometer (Spex Industries, Edison, NJ) on line with 
a microVAX computer for data storage, fitting, averaging, and presentation. 
Cells trypsinized and plated onto 11  x  22 mm glass coverslips (Thomas 
Scientific, Philadelphia, PA) 2 or 3 d before experiments were grown to near 
confluence in complete medium (DME without phenol red, with 10% FCS 
in  a  7%  CO2  incubator).  Slips  were  pretreated  with  human flbronectin 
(Rorer Biotechnologies, Inc.,  King of Prussia, PA) to improve adhesion. 
Cells were serum deprived for 24 h before experiments although starving 
for 6 h was found to be sufficient for maximal response to PDGF presenta- 
tion (data not shown). 
Cells Were washed once with incubation buffer (20 mM Hepes, pH 7.2, 
140 mM NaCI,  1 mM CaCI2, 5 mM KCi,  1 mM MgCI, and 10 mM glu- 
cose) and loaded with fura-2-AM (Molecular Probes, Inc., Eugene, OR). 
1/~1 of a 2.5 mM stock solution of fura-2-AM in dry DMSO (fresh daily) 
was added to 1 ml incubation buffer containing 1% BSA 0.04% pluronic 20 
detergent. This 2.5-#M solution of FURA-2-AM was vortexed for I rain and 
used immediately. Cells were incubated with this loading buffer for 30 rain 
at 25°C in the dark. After loading, cells were washed four times Over a 10- 
rain period with incubation buffer warmed to  37°C.  1 min before being 
recorded, cells were washed once and placed in the fluorometer cuvette as 
described above in incubation buffer without CaCh, but with 2 mM EGTA 
instead.  Hence all measurements were performed without external Ca  2+, 
but before intracelluiar stores of Ca  2+ were depleted. 
An 11  ×  22 mm coverslip with loaded cells was placed standing on end 
into a 10 ×  10 mm wide by 30 mm high quartz cuvette, with the slip seated 
snugly in the front corner of the cuvette along one vertical edge and against 
the center of the opposite wall of the cuvette along the other vertical edge. 
Glass clips were pulled from 25-~1  micropipettes (Drummond Scientific, 
Broomall, PA) and were used to hold the slip firmly in place. With this ge- 
ometry, approximately two-thirds of the surface area of the coverslip was 
used. The cells were excited by the incident beam 15"C from normal, and 
fluorescence emitted at an angle of 45  °  from normal was collected.  The 
fluorescence was  excited  at  340,  355,  and  370  nm,  and  emission was 
recorded  at 510  nm with 3-nm band widths.  A  long-pass filter,  OG455 
(Ditric Optics, Hudson, MA), was added to the emission path to cut down 
on the contributions of scattered and reflected low wavelength light, not 
sufficiently reduced by the monochromators. 
Cellular autofluorescence for excitation at each wavelength (measured on 
unloaded cells) was ,o10% of the measured values, and was subtracted from 
the measurements. Calcium concentration was estimated by comparison of 
the ratio of fluorescence with excitation at 355 rim, which was found to be 
the apparent isofluorescence  point for the fluorometer and bandwidths used. 
The 380/355 and 340/355 ratios were compared with those ratios obtained 
for standard CaCIzlEGTA  solutions and 1 #M fura-2 salt measured with 
our equipment according to the method of Grynkiewitcz et al. (1985). The 
estimates of  the Ca  2+ concentration from each of two ratios provided an ad- 
vantage in two ways: At low Ca  2+, the fluorescence at 340 tun excitation is 
low and therefore less accurate. The same is true for high Ca  2+ and 380 nm 
excitation. The accuracy can thus be improved at high and low Ca  2+ con- 
centrations by  using the average of the Ca  2+  estimates from each ratio 
weighted by the relative intensity at 380 and 340, respectively In addition, 
by comparing the Ca  z+ estimates from the ratios of 380/355 and 340/355 
fluorescence, data could be screened. Data that yielded inconsistent esti- 
mates from the two ratios (due presumably to poor estimates of the back- 
ground fluorescence  or poor loading) were not used. After 30 min of  loading 
with FURA2, cells to be pretreated were cooled to 4"C and 30 nM mAbl08 
was added for 10 min. These cells were then washed with the same proce- 
dure above, but with mAbl08 added at the same concentration. 
Intracellular pH Measurements 
The measurement  ofpH by the use of  BCECF fluorescence  on cells attached 
to coverslips within a cuvette was as previously described (Moolenaar et al., 
1988). 
Turnover of  Phosphatidyl Inositol 
Total  [3H]inositol phosphates were  measured as described (Tilley et al., 
1988).  Briefly,  cells plated in a 35-mm dish were labeled for 48 h  with 4 
#Ci [3H]inositol, and stimulated with different levels of EGF in the pres- 
ence of 10 mM LiCI for 30 min, and the reaction stopped by addition of 
ice-cold TCA (10%  wt/vol). Soluble material was washed with diethylether 
and neutralized extracts were  processed for analysis of total  [3H]inositol 
phosphates by anion-exchange chromatography (Tilley et al.,  1988). 
Cell Treatments for Kinetics Studies 
Cells at confluence on 24-well plates were washed once in DME without 
serum and then incubated in this medium plus 100 nM PMA (diluted from 
a  100 t~M stock solution in 10% DMSO) at 37°C for 45 rain. Equilibrium 
or kinetics experiments were then performed immediately in the absence 
of PMA. Cells were treated with mAbl08 as follows. Immediately before 
experiments, cells were  washed in DME  without serum at 40C  and in- 
cubated in this medium  plus 30 nM mAbl08 at 4°C for 30 min. Experiments 
were then performed in the continued presence of this concentration of 
mAbl08. 
Dissociation Experiments 
Cells were allowed to bind radioiodinated EGF for 90 min as for equilib- 
rium experiments. 5.0 ng/ml (= 0.83 nM) radioiodinated EGF was used for 
all experiments. Where indicated,  120 ng/ml unlabeled EGF was added to 
yield a final ligand concentration of 20.6 nM. Then cells were washed three 
times with 1.5 ml of cold binding buffer over a 3-rain period and were left 
in 1.5 mi of this buffer plus 50 nM unlabeled EGE At various times cells 
were washed twice with cold binding buffer Over 1 rain,  solubilized, and 
counted as for equilibrium experiments. Experiments were performed in 
duplicate and at least twice. The 3-rain wash after binding was used to allow 
sufficient time for the dissociation of low-affinity nonspecific interactions. 
In experiments  performed in the presence of  excess  unlabeled ligand washed 
three times in 15 s, we have seen a decay time for these nonspecific interac- 
tions of  0.2-0.3 min (unpublished results). Using the l-rain wash  procedure, 
the contribution of these transitory nonspecific interactions was reduced. 
Parallel data taken in the presence of 1 /~g/rnl unlabeled EGF were sub- 
tracted from all data to correct for nonsaturable binding. 
Association Experiments 
Cells were washed twice in binding buffer at 37°C.  Cells were then in- 
cubated in 1 ml of 37°C binding buffer with radioiodinated EGF in a 37°C 
water incubator. The 1-ml volume was added quickly to individual wells 
with 15 or 30 s delay between time of addition to replicate wells. At various 
times (ranging from 30 s to  l0 rain) after the binding was begun each in- 
dividual well was washed twice with 1.5 ml binding buffer at 40C and the 
cells were solubilized and counted as for the other experiments. As men- 
tioned above, the 1-min wash after binding was used to decrease the contri- 
bution of low-affinity nonspeciflc interactions. With this l-rain wash, non- 
specific binding remained at 20%  of the lowest specific binding values 
measured. In trial experiments using only a  10-s wash period, nonspecific 
binding was 50%  of total  binding (with  no difference in the shapes of 
specific binding curves). Because the off-rate of EGF binding ranged from 
40 to 60 rain of half time at 4°C, the use of a l-rain wash could have allowed 
no more than 2 % of specifically bound ligand to have dissociated. More- 
over, as the concentration of radioligand was reduced by >100-fold within 
7 s (by the two 1.5-ml washes), the binding of  additional ligand that occurred 
during the l-rain wash must have been <2 % of that bound within the first 
(30 s) incubation time. 
Calculations and Fitting Procedure 
For  the  association experiments concentrations  of radioiodinated  EGF 
ranged from 0.11  to 27 riM.  Two  125-t~1 aliquots of each dilution were 
counted and used to normalize data. Counts bound (average of two determi- 
nations) minus  counts  bound in the presence of I #g/ml unlabeled EGF were 
divided by counts added to calculate the fraction of the initial EGF concen- 
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centration). Fractional  specific  binding data were  fit by  nonlinear least 
squares (Bevington,  1969) to the equation in the legend to Fig. 8. This equa- 
tion was integrated numerically to calculate the function value at each time 
and EGF concentration. Integral summation was performed at 0.1-s incre- 
ments (values were changed <0.5 % by integrating at 1- or 0.1-s increments). 
Untreated cells and cells pretreated with mAbl08 were assayed on the same 
day from cells plated at the same time, with the same dilutions of radioligand 
while cells treated with PMA were assayed on a different day at a different 
cell density. 
Results 
Characterization  of the mAbs 
Fig.  1 demonstrates the specificity of mAb96 and mAbl08 
towards  the  human  EGF-R.  Both  antibodies  specifically 
precipitated  the  M:170,000  human  EGF-R  from  HER14 
cells and not the murine or chicken EGF-R from Swiss 3T3 
cells expressing endogenous murine EGF-R or CER cells 
expressing chicken EGF-R (Lax et al., 1988,  1989), respec- 
tively. In contrast, RK2 (Kris et al.,  1985), a rabbit poly- 
clonal antibody directed against a peptide within the intra- 
cellular domain of the EGF-R precipitated the EGF-R from 
all three species. Both mAb96 and mAbl08 precipitated a 
nonglycosylated M:130,000 protein from HER14 cells pre- 
treated with tunicamycin to prevent glycosylation (data not 
shown). 
The  data  presented  in  Table  I  show  that  mAb96  and 
mAbl08 do not compete for binding to the EGF-R. Whereas 
rnAb96  and  EGF  compete  with  each  other  efficiently, 
mAbl08 and EGF do not. Hence mAb96 and EGF bind at 
or near the same site, whereas mAbl08 binds at a distinct 
site.  Further,  mAbl08  can  immunoprecipitate ~25I-EGF if 
cross-linked to the receptor, demonstrating that both ligands 
can bind to the same receptor molecule (data not shown). 
Radioiodinated mAbl08 bound to the EGF receptor on the 
surface of HER14 cells with a dissociation constant (Kd) of 
Figure 1.  Specificity of Anti-EGF-R mAbs mAb96 and mAbl08. 
Immunoprecipitates of solubilized extracts from  [35S]methionine- 
labeled  cells  were  analyzed  by  SDS-polyacrylamide  gels  (7%). 
Cells expressing the human (H), chick (C), and mouse (M) EGF-R 
were used. Unlike Ab RK2 (directed against the intracellular kinase 
domain of the EGF-R), both mAb96 and mAbl08 were specific for 
the human receptor. 
Table L Cross Inhibition of  Saturable Binding 
Radiolabeled  ligand 
Unlabeled 
competing ligand  '~I-EGF  nSI-mAb96  12SI-mAb108 
Control  555*  1,008  482 
330 nM EGF  -  107  (90%)  524  (-9%) 
1 #M mAb96  0  (100%)*  -  415  (14%) 
6 ILM mAbl08  433  (22%)  945  (6%)  - 
HERI4 cells grown to confluence in 24-well plates were preincubated at 4oc 
for 90 min with unlabeled mAb96, mAbl08, or EGF at the saturating doses 
listed. Then radioiodinated mAb96, or mAbl08, or EGF was added to each 
well, and incubation continued for another 90 rain at 4°C. Final concentrations 
of radioligand were 80 nM :~I-EGF,  18 nM :251-mAb108, and 3.4 nM :2sI- 
mAb96. The radioactivity that remained cell-associated after 3 rain of washing 
was counted in a gamma counter. 
* Counts per minute x  10  -3 cell associated, after subtraction of nonsaturable 
binding (counts bound in the presence of excess of the same unlabeled ligand; 
<20% of total binding for each radioligand. Values are mean of triplicates, SD 
<5%  of  each mean). 
~:  Percent  inhibition. 
2.0 riM, and an estimated number of binding sites of 4.6  x 
105 (Fig.  2).  This number of sites is roughly equal to the 
number of sites for EGF, suggesting that mAbl08 binds with 
a  1:1 stoichiometry to all of  the EGF-R on the surface of  these 
cells. The dissociation constant for mAb96 was found to be 
0.8 nM (data not shown). In the presence of EGF, the affinity 
of mAbl08  was  reduced to a  Kd of 5.0  nM,  whereas the 
number of sites was little changed (Fig.  2). 
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Figure 2. Binding of mAbl08 to HER14 cells. The binding of radio- 
iodinated mAbl08 to HER14 cells is plotted as bound versus free 
(inset)  and in  Scatchard analysis  for control cells  (o)  and cells 
preincubated and incubated in the presence of 30 nM EGF  (o). 
Details are presented in Materials and Methods. The values of the 
fitted equilibrium dissociation constants were 2.0 nM without EGF 
and 5.1  nM in the presence of EGF. The numbers of binding sites 
were 4.1  x  105 and 4.6  x  105,  without and with EGF,  respec- 
tively. Curves were fit for simplicity of interpretation to the binding 
equation assuming a  single affinity, even though both Scatchard 
curves appear curvilinear. The nonlinearity appeared both with and 
without EGE and was reproducible. The origin of this effect is not 
known, but may be due to a reduction in the stoichiometry of anti- 
body binding with increasing concentration. This effect appears to 
have nothing to do with the dual affinities of EGF binding, as cur- 
vilinearity remains for TPA pretreated cells (data not shown). 
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Fig. 3 shows that in a competition binding experiment, both 
mAb96 and mAbl08  interfere with the specific binding of 
radioiodinated EGF to HER 14 cells, mAb96 completely in- 
hibited the binding of 1.7 nM '2~I-EGF with a concentration 
at half-maximal inhibition estimated to be 0.2 nM. The pres- 
ence of mAbl08 led to only a 50%  inhibition of binding of 
EGF at the concentration of radioligand used, even for con- 
centrations of antibody >20 nM. The concentration of anti- 
body needed to produce half of this inhibition was 2.7 nM. 
These effects of the antibodies on the binding of EGF were 
identical for the inhibition of binding of radioiodinated TGFt~ 
(Fig.  3). 
To further understand the inhibition of binding of EGF by 
the antibodies, Scatchard analyses of the binding of the hor- 
mone with and without 30 #g/ml of either one of the two anti- 
bodies were performed (Fig. 4). As has been shown before 
(reviewed in Carpenter, 1987; Schlessinger, 1986) the bind- 
ing of radioiodinated EGF occurred with a nonlinear Scatch- 
ard curve, which could be fit by assuming two populations 
of receptor with dissociation constants, K,  =  0.2  nM and 
K2  =  10 nM,  at 4°C. 
Fig.  4  B demonstrates that mAb96 completely inhibited 
the binding of EGF at all EGF concentrations. The effect of 
the presence of a saturating level of mAbl08 on EGF binding 
was  quite different (Fig.  4  A).  There was  a  considerable 
reduction in the amount of EGF bound at low receptor oc- 
cupancy, but little reduction at high receptor occupancy. For 
a two-population analysis, this translates to a reduction in the 
assessed number of high-affinity binding sites from 19,000 
to 2,000, with no discernible effect on the affinity or number 
of the low-affinity binding sites. In four repetitions of Scatch- 
ard  binding  for  mAb108-pretreated  cells,  the  number  of 
high-affinity sites as estimated by the fitting program was 
consistently reduced, although to a variable degree, whereas 
little effect on the estimated number of low-affinity sites was 
seen (data not shown). On the average the number of high- 
affinity sites was reduced by 9-fold and the number of low- 
affinity sites was reduced by 1.2-fold. As shown in the figure, 
the effects of mAbl08 pretreatment appear similar to that of 
pretreating cells with one of the active phorbol esters, phor- 
bol myristate acetate (PMA). We note that mAbl08 binding 
to  HER-14  cells  is  unchanged  after treatment  with  PMA 
(data not shown). 
Effect of  mAbl08 Binding on Early Responses to EGF 
Autophosphorylation of the EGF-R 
Fig. 5 displays the effects of mAbl08 pretreatment on one of 
the earliest responses to EGE the autophosphorylation of  the 
EGF-R. Autophosphorylation of EGF-R was stimulated for 
2  min  with  EGE  and  was  analyzed by immunoblot with 
anti-phosphotyrosine-specific polyclonal rabbit  antibodies 
(Fig. 5, A and B). The Mr-170,000 band was demonstrated 
to be the EGF-R of unchanging quantity by immunoblotting 
with an anti-EGF-R antibody, RK2  (Fig.  5  C).  Fig.  5  D 
presents these results after quantitation by counting of gel 
slices, mAbl08 inhibited the response to the lower concen- 
trations of EGE 0.3 and 0.g nM by 52 and 43 %, respectively. 
At the larger doses, however, mAbl08 had no effect, On the 
other hand, mAb96 blocked the response to fully saturating 
EGF (data not shown). 
Release of  Calcium from IntraceUular Stores 
Fig.  6  A demonstrates the effect of mAbl08  on the EGF- 
induced  change  in  intracellular  free  Ca  2+  concentration. 
The dose response of EGF showed that at high EGF concen- 
trations, the response was larger in magnitude and occurred 
more rapidly. Just as for autophosphorylation activity, at the 
lower  concentrations  of  EGE  mAbl08  pretreatment  in- 
hibited the response, whereas at the higher concentrations of 
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Figure 3. Inhibition of EGF and 
TGF binding by mAb96 and mAb- 
108. The amount of specific bind- 
ing of radioligands to HERI4 cells 
is  plotted.  Cells  were  preincu- 
bated either with afffinity-purified 
mAbl08 (open symbols) or with 
mAb96 as  isolated IgM (closed 
symbols) for 90 rain at 4°C, and 
then  1.7 nM radioligand was al- 
lowed to bind to the cells for 90 
min at 4°C. Plotted are: ~2~I-TGF 
c~ binding to cells pretreated with 
mAbl08  (o),  125I-EGF binding 
to cells pretreated with mAbl08 
(A),  ~2~I-TGFc¢ binding  to  cells 
pretreated with mAb96 (e), '2~I- 
EGF binding to cells pretreated 
with mAb96 (A). The molar con- 
centrations at which 50%  effect 
occurred were 2.7 and 0.2 nM for 
mAbl08 and mAb96, respectively. 
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Figure 4. Effect of antibody pretreatment on EGF 
binding. The binding of radioiodinated EGF to 
HERI4 cells is plotted in bound vs. free format (in- 
sets) and  in  Scatchard analysis. Plotted are  the 
binding curves for control cells (e) and for cells 
pretreated  and  incubated  either with 30  nM 
mAbl08 (o, A) or with 6 nM mAb96 (zx, B). By 
nonlinear least squares fitting to the binding equa- 
tion (without inversion) assuming two populations 
of receptor, the low-affinity  population bound EGF 
with  a dissociation constant (Kd) of 14 nM,  at 
500,000 sites per cell. In the presence of mAbl08 
these  values were little changed, to  22  nM  at 
490,000 sites per ceil. The high affinity population 
bound EGF with K~ of 0.17 nM at 19,000 sites per 
cell without  antibodies. In the presence of mAbl08, 
these values were reduced to 0.04 nM and  1,900 
sites per cell. 
EGF, the inhibition was overcome, mAb96 blocked the re- 
sponse to even the highest level  of EGE 
Production of  lnositol Phosphates 
The amount of total inositol phosphates formed after 30 rain 
of stimulation with different concentrations of EGF is shown 
in Fig.  6 B. The dose response curve was similar to that for 
Ca  2+  release  and autokinase activity.  At 0.8  nM  EGE  the 
lowest  dose of EGF eliciting a  response,  mAbl08 blocked 
the response. At the higher doses, however, the antibody had 
little  effect. 
Elevation of Cytoplasmic pH 
Fig. 6 C shows the dose-response data for the amount of the 
change in cytoplasmic pH stimulated by EGF and the effects 
of mAbl08 pretreatment.  The dose response is very similar 
to that for all  the other early responses tested.  At the low 
doses of 0.8 and  1.7 nM EGE the responses were inhibited 
by 55 and 45 %, respectively.  At the saturating dose of 17 nM 
EGE however,  no inhibition was  seen. 
The effects of mAbl08 were hence the same for all of the 
early responses to EGF tested.  At the lowest concentrations 
of EGF,  at  those concentrations approaching the  level  of 
EGF in vivo, mAbl08 exerted an inhibitory effect,  ranging 
from 50 to  100%.  For all  early responses,  inhibition  was 
overcome with higher,  saturating levels  of EGE 
Kinetics of EGF Binding 
To determine the effects of mAbl08 on the amount of EGF 
bound quickly at 37°C and to more directly relate the short- 
term effects with the effects on EGF binding, the kinetics of 
EGF binding were measured. The dissociation rates (Fig.  7) 
had to be measured at 4°C (to prevent internalization),  where- 
as the association rates were measured directly at 37°C. 
Surprisingly, the rate of dissociation was little affected by 
the presence of mAbl08, by PMA pretreatment or by changes 
in  receptor occupancy. The pretreatments  and  high occu- 
pancy would be expected to report dissociation from low- 
affinity sites, and low receptor occupancy that from high- and 
low-affinity  sites  in roughly equal proportion (according to 
the equilibrium binding data,  Defize,  1989). 
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ther pretreated with 30 nM mAbl08 for 30 min at 4°C (+ mAbl08, 
open  bars)  or pretreated  with  buffer alone  (-  mAbl08,  cross- 
hatched bars), and then stimulated for 2 min with various levels of 
EGE SDS-polyacrylamide-separated  proteins transferred to nitro- 
cellulose paper were immunobiotted with anti-phosphotyrosine  an- 
tibodies (A and B) or with anti-EGF-R (RK2) antibodies (C). For 
improved comparisons, the phosphotyrosine blot was exposed twice, 
the left side (A) for 6 h and the right side (B) for 2 h. The specific 
phosphotyrosine activity for each treatment is plotted in D. Bands 
cut from the blots were counted and the specific activity was calcu- 
lated for each band as the ratio of the counts by phosphorylation 
blot divided by the counts for the same band by anti-EGF-R blot 
after subtraction of nonstimulated counts. The percents of inhibi- 
tion of EGF-stimulated phosphokinase activity by mAbl08 analyzed 
in this way were 52, 43,  13, and  -5%  for stimulation with 2, 5, 
25, and 125 ng/ml (0.33, 0.83, 4.1, and 21 nM) EGF, respectively. 
Fig. 8 displays the results of short-term association experi- 
ments measured at 37°C.  Data (symbols)  and fitted values 
(lines)  were plotted as  fraction of total ligand  bound  as a 
function of time. The data were fit as described in Materials 
and Methods to the equation given in the figure legend. The 
fitted values for these experiments are listed in Table II along 
with  the  apparent  dissociation  constants  (Kd) calculated 
from these parameters. 
For a ligand binding with a single on-rate constant; the ini- 
tial slopes of the fraction of ligand bound as a  function of 
time would be the same, that is, the initial rate of ligand bind- 
ing would be proportional to ligand concentration. This was 
not the case for the untreated cells (Fig. 8A). Theearly data 
points and fitted curves displayed a higher initial rate of frac- 
tional binding at the lowest EGF concentrations. These data 
were fit to five parameters (refer to the equation in the figure 
legend), including separate terms for high- and low-affinity 
binding. The parameters are listed in Table II. The inclusion 
of the two terms for high-affinity on-rate constant and high- 
affinity receptor concentration decreased X  2 by 3.6-fold, and 
by F test (Bevington, 1969), there was a probability of only 
1% that the improvement of the fit was random (PF =  0.01). 
Fitting of these data with a  single on-rate but different off- 
rates for high- and low-affinity receptors did not significantly 
improve the fit (P ~  0.5,  data not shown). Treatment of the 
cells with PMA (Fig.  8 B) or with mAbl08 (Fig.  8  C) re- 
duced the binding curves to EGF binding that scaled with 
EGF  concentration.  These  data  were  fit  well  with  three 
parameters including a  single on-rate. Inclusion of the two 
additional  high-affinity  terms  reduced  the  X  2  value  by 
<10%,  with PF ~  0.5,  showing no significance to the im- 
provement of the fit. 
The fitted 37°C kinetics parameters listed in Table II agree 
well with the 4°C equilibrium binding results listed in the 
legend to Fig. 4. The dissociation constants estimated as the 
dividend  of  off-  and  on-rate  constants  agree  with  those 
directly measured at 4°C,  as do the total receptor number 
and relative amounts of high- and low-affinity receptors. It 
should be pointed out that our data analysis did not include 
terms for internalization of EGF and receptor. Because inter- 
nalization of the ligand will prevent dissociation, this omis- 
sion would be expected to lead to an underestimate of the off- 
rate constant and apparent dissociation constants reported in 
Table II. However, elevation of the rate of fractional associa- 
tion of EGF at low concentrations was not dependent on in- 
ternalization, as treatment of cells with 20 ttM phenylarsine 
oxide was found to inhibit internalization  and  slightly  in- 
crease rather than decrease association by 10-20%, but not 
have effect on the elevation of initial rate of fractional binding 
at low EGF concentrations (data not shown). 
Discussion 
The binding of EGF to its receptor occurs with a typical non- 
linear Scatchard curve, in which the amount of EGF bound 
at low EGF concentrations is higher than one would predict 
for simple binding of one ligand to one receptor of a single 
affinity.  This characteristic holds whether the EGF receptor 
is  expressed  in  its  natural  environment,  is  expressed  to 
greatly elevated levels in naturally arising carcinoma cells, 
or is expressed in a foreign, cross species environment at any 
of a  wide variety of expression levels (reviewed in Schles- 
singer,  1988).  One simple model for nonlinear behavior of 
this kind is the postulation of two states of the ~'eceptor that 
differ in their affinity for the ligand (reviewed in Carpenter, 
1987;  Schlessinger,  1988).  It should be pointed out,  how- 
ever, that no direct evidence exists to prove that there are two 
different populations of EGF receptor with different affinities 
for EGF. Other models, such as cooperative binding or the 
postulation of a larger number or continuous distribution of 
affinity states could be consistent with the observations as 
well. Elevation of EGF binding at low EGF concentrations 
is not, however, an artifact of the equilibrium binding assay, 
as three very different cell treatments result in linearization 
of the Scatchard binding curves: (a) treatment of cells with 
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mobilization,  inositol  phosphate 
production, and pH elevation. (A) 
The elevation of cytoplasmic Ca  2+ 
levels  in populations of cells  in 
response to various levels of EGF 
was followed by monitoring Fura- 
II fluorescence (see Materials and 
Methods). Cells were incubated in 
the absence of extraeellular  Ca  2+ 
during the measurement.  The rate 
and magnitude of  the response in- 
creased with increasing EGF from 
0.8 to 80 nM (= 500 ng/ml) EGF 
(o). Cells pretreated  with 30 nM 
mAbl08 (o) showed reduced and 
delayed responses at the lower but 
normal  responses  at  the  higher 
EGF  concentrations.  Cells  pre- 
treated with 1 nM mAb96 showed 
no response to EGF even  at 80 
nM EGF (n).  Representative  er- 
ror bars (SEM, n  =  3 or 4) are 
shown.  (B) The relative  amount 
of total  [3H]inositol  phosphates 
formed in 30 min of stimulation 
of cells with various levels of EGF 
is plotted  for cells  not pretreated 
(o) and for cells  pretreated  and 
kept  in the  presence  of 36  nM 
mAbl08 (o). (See Materials  and 
Methods for details.)  Representa- 
tive SE bars are shown. The basal 
signal  was  650  +  35  cpm/106 
cells per 30 min.  (C) The eleva- 
tion of intracellular  pH after  10 
min  of stimulation  by  different 
levels of EGF is plotted for cells 
pretreated  for 20 min with 36 nM 
mAbl08 (open bars) and control 
cells  (cross-hatched bars). The 
ranges of  the inhibition of  the ele- 
vation  of the pH responses  were 
50-60% and 40-50%  for stimu- 
lation by 5  and  10 ng/ml EGF, 
respectively. 
one of the active phorbol esters (Shoyab et al.,  1979 and Fig. 
4), (b) binding of EGF to EGF-R deletion mutants in which 
a large portion of the cytoplasmic domain had been removed 
(Livneh et al.,  1986), and (c) as presented here the binding 
to  saturation  of an  anti-EGF-R  mAb.  In  addition,  high- 
affinity  binding  can  be  demonstrated  in  the  short term  at 
physiological temperature with kinetics measurements (Fig. 
8 and Table II), obviating the need for meeting the assump- 
tions of the equilibrium  experiment. 
I. The Inhibition of High-AJ~inity Binding by mAbl08 
We have shown that mAbl08 binds specifically to the human 
EGF-R without blocking EGF binding. This was unlike the 
results for EGF and mAb96, which compete for the same site 
on the EGF-R. Binding of saturating  levels of mAbl08 re- 
duced the level of EGF binding at equilibrium only at low 
concentrations of EGE The estimated number of high-affin- 
ity  receptors  was  reduced  from  19,000  to  roughly  1,900, 
whereas there was little effect on the number or affinity of 
low-affinity  receptors.  Conversely,  the  binding  of EGF  at 
saturation  reduced the affinity of mAbl08 two to threefold. 
In addition to this analysis of the effects of mAbl08 on the 
equilibrium  binding of EGF at 4°C,  we have measured the 
association kinetics of EGF binding at 37°C as a function of 
EGF concentrations. We report the same conclusions by ki- 
netics: high-affinity EGF receptors make up 1-2 % of the to- 
tal,  and have an affinity that is 40 times higher than that of 
low affinity receptors,  mAbl08 prebinding,  similar to PMA 
treatment,  inhibited  high-affinity  binding  alone.  Further, 
high-affinity receptors displayed an elevated rate of associa- 
tion for EGF (rather than a  prolonged rate of dissociation) 
as compared with low-affinity receptors, mAbl08 and PMA 
were found to inhibit the rate of EGF binding at 0.1-0.3 nM 
EGF by 40 %,  but not at all  at 5-27 nM EGF (and neither 
agent had an effect on the rate of EGF dissociation at 4°C). 
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Figure 7. Rate of dissociation of EGF. After binding of J25I-EGF at 
4°C for 90 min, cells were washed and left in PBS with 50 nM EGE 
Plotted is the amount of ~25I-EGF (as percent of initial binding) 
which remained cell associated during the wash. Cells were pre- 
bound with either 0.8 nM radioligand plus 20.2 nM unlabeled EGF 
(s), or with 0.8 nM radioligand (.), or else cells were prebound 
with 0.8 nM radioligand after being pretreated with 100 nM PMA 
for 30 min at 37°C (-), or with 30 nM mAbl08 for 30 min at 4°C 
(e). The counts bound at zero time of wash were 1,200, 13,914, 
7,502, and 7,758 for the four conditions listed, respectively. Data 
were fitted to exponential decay curves, yielding decay times of 20 
+ 9, 41 +  15, 34 + 4, and 35 +  10 min, respectively, with reduced 
X  2 values of 4.1, 14.2, 2.1, and 8.8, respectively. 
These conclusions have been confirmed as well for A431 hu- 
man carcinoma cells and  for cells expressing a  truncated 
EGF-R,  which  have reduced high-affinity binding  (manu- 
script in preparation). 
Hence, both by equilibrium binding at 4°C and by kinetics 
analysis at 37°C, mAbl08 specifically inhibits high-affinity 
EGF binding. The molecular mechanism whereby this inhi- 
bition occurs is not clear. Because the number of binding 
sites for mAbl08 and EGF are the same even when both are 
present at saturation, it is unlikely that mAbl08 binds exclu- 
sively to the high-affinity receptor and  directly interferes 
with EGF binding.  If we suppose that the high- and low- 
affinity receptors exist in equilibrium then one possibility 
consistent with our data is that mAbl08 binds preferentially 
to the EGF-R in the low affinity state, and pulls the equilib- 
rium to favor this state.  We have no data addressing this hy- 
pothesis at present. 
H. The Nature of High-AJfinity Binding 
Contrary to the notion that receptor affinity is regulated by 
off-rate, we have shown that high-affinity binding is due to 
an elevated rate of association.  Evidently the high-affinity 
EGF-R exists before EGF binding, and is more accessible or 
perhaps more electrostatically attractive to diffusing ligand. 
We note that our measurements of rate constants approach 
values measured before: the binding  of EGF to placental 
membranes at 0.4 nM EGF has been measured at 2.6 ×  106 
M-l.s  -',  and  the  off-rate  has  been  measured  at  6.1  × 
10-4.s  -1, both at 23°C.  (Hock and Hollenberg,  1980). By 
Scatchard  analysis  these  membranes  displayed  a  single, 
high-affinity with a K~ of 0.4 nM. These values are in good 
agreement with our values for the high affinity receptors. 
The existence of high- and low-affinity EGF binding has not 
before been demonstrated with kinetic measurements, that 
is,  neither the off-rate nor the on-rate of binding has been 
shown to be concentration dependent. An occupation-depen- 
dent rate of dissociation has been demonstrated for A431 
cells, presumably due to preferential rebinding of newly dis- 
sociated hormone at moderate levels of occupancy (Wiley, 
1988). However, this more common effect is most likely due 
to the very high local density of receptors restricted to the 
cell surface (Wiley, 1988; DeLisi and Wiegel, 1981), and this 
kind of effect cannot in itself affect the shape of a Scatchard 
curve (DeLisi and Wiegel, 1981). We believe the on-rate con- 
stant has not before been shown to be concentration depen- 
dent because a wide range of ligand concentrations had not 
been used in association-rate measurements. 
Our  finding that the difference between high- and  low- 
affinity receptors is determined by the rate of association, 
rather  than  dissociation,  has  a  precedent  in  growth  fac- 
tor-growth factor receptor interactions.  High-affinity IL 2 
receptors have a  1,000-fold higher affinity for IL 2 than do 
the  low-affinity receptors,  and  this  difference stems  from 
a  difference in the  rate of ligand  binding  (Lowenthal and 
Greene,  1987).  However, it should be pointed out that the 
molecular mechanism for this wide difference in affinity for 
IL 2 receptor is different from that for the EGF-R. For the 
former,  high-affinity binding  occurs  to  different receptor 
subunits,  whereas  for EGF-R both high- and  low-affinity 
binding is through the same EGF-R molecule, as evidenced 
by the fact that cells transfected with one wild-type receptor 
gene display both affinities (reviewed in Schlessinger, 1986, 
1988). 
III. High-AJfinity Receptors Are Important for 
Signal Transduction 
Our data show that the specific inhibition of high-affinity 
EGF binding by mAbl08 correlates with inhibition of re- 
sponses to low doses of EGF for all early cellular responses 
tested. These results suggest that high-affinity EGF binding 
plays an important role in EGF signal transduction. This has 
been proposed before to  explain  why  the  IDs0 for EGF- 
stimulated cell proliferation (measured at 46 pM for human 
foreskin fibroblasts, see Carpenter and Cohen, 1975) is nearly 
the same magnitude as the Kd for high-affinity binding, but 
is 2 orders of magnitude lower than the Kd for low-affinity 
binding. The demonstrated functionality of high affinity bind- 
ing is also important physiologically, because the level of 
EGF is extremely low in serum, ranging from 20 to 27 pM 
(Hirata and Orth,  1979), and in tissues, ranging from 1 to 
5 ng/g (Hirata et al., 1980). Further, two reports demonstrate 
that mAbl08 treatment inhibits the growth of human tumor 
cells in culture and in nude mice (Aboud-Pirak et al.,  1988, 
1989).  These data taken together support the notion that 
high-affinity EGF binding  is the primary means whereby 
EGF stimulates cells in vivo. 
Inhibition of high-affinity EGF binding reduces responses 
and cell growth, and hence high-affinity binding is used in 
cell  stimulation,  but  is  it  necessary?  Is  the  high-affinity 
EGF-R the only active moiety, or can EGF stimulate cells 
through interaction with the receptor in the low-affinity state? 
This is a difficult question, especially when the actual num- 
ber of activated EGF-R molecules required is not known. As 
a first approach, we were interested in determining whether 
inhibition of short-term  responses by  mAbl08  correlated 
with inhibition of EGF-R occupancy at corresponding times. 
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A  correlation of this kind has been demonstrated between 
long-term EGF-R occupancy and mitogenesis (Knauer et al., 
1984). To do so required measurement of  the kinetics of EGF 
binding to these cells as affected by mAbl08. As mentioned 
4  $ 
Time  (minutes) 
Figure 8. Rate of EGF association. The fraction of added ]25I-EGF 
specifically bound to HER14s is plotted as a function of time for 
control  cells  (A), cells  prebound  with  mAbl08  (B),  and  cells 
pretreated with PMA (C). In A and B the concentrations of EGF 
added were 0.11 (*), 0.33 (o), 1.0 (¢), 3.0 (zx), 9.0 (lower o), and 
27 nM (D). In C, the concentrations were 0.1 (*), 0.5 (*), 2.5 (zx), 
and 12.5 (o) riM. Lines drawn present the fitted curves for numeri- 
cal integration of  the equation below giving the concentration of  oc- 
cupied receptor (divided by the initial EGF concentration).  For 
control cells (A), five parameters were included in the fitting includ- 
ing two separate on rate constants. For treated cells (B and C), three 
parameters were used including only one on rate constant. The un- 
certainties for data points 0eft off  for clarity) ranged for 10 % of the 
values (for the 0.1-nM curves) to 5% for the curves with highest 
ligand concentrations. 
above, we found that mAbl08 prebinding reduced by roughly 
40% the initial rate of EGF binding for low EGF concentra- 
tions (0.1-0.3 nM) but not for high concentrations (>5 nM). 
Hence for the early responses measured.here (1-2 min except 
for phosphatidylinositol turnover), there is a good correla- 
tion between the amount of EGF-R occupied and the magni- 
tude of the response, disregarding whether that receptor was 
initially high or low affinity.  This may suggest that high- 
affinity receptors are important for stimulating cells at low, 
physiological doses of ligand, but that in their absence occu- 
pation of low-affinity receptors is sufficient. On the other 
hand, there may be enough high-affinity receptors left after 
mAbl08  treatment for cell stimulation provided a  higher 
EGF  concentration is  used.  Alternatively,  occupied low- 
affinity receptors may be converted to the high-affinity state 
before they are active. 
We continue to favor the supposition that the high-affinity 
EGF-R  is  required,  and  restate  the  allosteric  activation 
model, modified by new evidence, as a working hypothesis: 
the  conformation of the  EGF-R,  which  has  the  highest 
affinity for EGF and binds EGF much more rapidly, is the 
most active conformation in terms of kinase activity and 
therefore signal transduction. The binding of EGF stabilizes 
this species and thus elevates the concentration of the active 
transducer. The high-affinity active state of EGF-R appears 
to  be  stabilized  by  oligomerization  (at  least  for purified 
receptor, Yarden and Schlessinger,  1987), by sphingolipids 
(Davis et al., 1988), and by EGF binding. Accordingly, EGF 
binding promotes receptor oligomerization (Cochet et al., 
1988) and activates EGF-R, leading to a stimulation of cell 
growth. Finally, EGF-R in the low-affinity state, which may 
prefer monomeric form, appears to be stabilized by mAbl08, 
by phosphorylation by kinase C (Davis, 1988), or by removal 
of a large portion of the cytoplasmic domain of the receptor 
(Livneh et al.,  1986). 
The question of the significance of EGF-R oligomeriza- 
tion, not directly addressed in this report, remains open. 
EGF binding promotes dimerization in living cells (Cochet 
et al.,  1988), and in purified EGF-R preparations (Yarden 
and Schlessinger,  1987).  Additionally, EGF-R dimers iso- 
lated by sucrose density gradient centrifugation bind EGF 
with higher affinity and demonstrate elevated kinase activ- 
ity compared with monomers (Boni-Schnetzler and Pilch, 
1987). However, the inhibition of high-affinity EGF binding 
d[E:R]  =  d[E:R]m + d[E:R]lo 
dt  dt  dt 
=  ko..m  [EGF] [R]h  i +  kon,lo [EGF] [R]lo 
-  ~  ([E:Rl)hi +  ([E:R])Io 
where 
[E:R]hi and [E:R]lo 
*[R]hi,  *[R]to 
*kon,hi, *kon,lo 
*ko~ 
(* Fitted values.) 
=  concentrations of occupied high- and 
low-affinity receptors, respectively; 
=  concentrations  of unoccupied high and 
low receptors, respectively; 
=  on-rate  constants for high- and low- 
affinity receptors, respectively; and 
=  rate  constant of dissociation (assumed the 
same for high- and low-affinity 
receptors, respectively. 
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HERI4  k~  Receptors/Cell  ko~  App.  K~ 
M-Is  -~ x  I0  -~  s  -l x  l0  s  nM 
Control  High:  98.1 +  2.3  7,120 (1.8%)  2.9 +  0.2  0.30 
Low:  2.54 :I:  0.38  388,000  2.9 +  0.2  I  1.4 
PMA-treated  3.68 +  0.42  354,000  1.9 ±  0.3  5.  I 
+mAbl08  4.56  ±  0.31  348,000  4.6  ±  0.3  9.6 
Listed are the binding parameters fired to the equation given in the legend to Fig. 8, along with the apparent dissociation 
/~,e by k~.  Uncertainties listed were as estimated by the nonlinear fitting  procedure on the data shown. Receptors/cell was 
receptor concentration, [R], by dividing by the number of cells assayed and multiplying by the volume. The reduced X  2 (the 
of freedom) were 2.1,  3.1, and 2.3,  for the control (fit to two on-rates), PMA- and mAbl08-treated cells (each fit to one 
constant, Kd, derived from dividing 
calculated from the fitted parameter 
X  2 divided by the number of degrees 
on-rate) respectively. 
and kinase activity by PMA stimulated phosphorylation  of 
EGF-R by kinase C,  has been shown  with  cross-linking 
studies to be independent of receptor dimerization (North- 
wood and Davis, 1989). Perhaps nonphosphorylated EGF-R 
is regulated through EGF promoted oligomerization,  where- 
as kinase C-phosphorylated EGF-R is regulated by a separate 
mechanism. In this regard, we have preliminary evidence to 
suggest  that  mAbl08  inhibits  EGF-R  oligomerization  as 
judged by cross-linking on living cells, supporting the notion 
that  without  PMA  treatment,  high-affinity  binding  and 
receptor oligomerization  are causally related. 
Received for publication  13 April  1989 and in revised form 20 October 
1989. 
Note Added in Proof. In a complementary study, Defize et al. (1989) re- 
cently reported that a different mAb inhibits low- but not high-affinity EGF 
binding, and does not inhibit early cell responses to EGF. In accord with 
our conclusions, those authors concluded that high-affinity EGF receptors 
are the active receptors in signal transduction. (Defize, L. H. K., J. Boon- 
stra, J.  Musenhelder, W.  Kruijer,  L.  G.  J.  Tertoolen, B.  C.  Tilly,  T. 
Hunter,  P.  M.  P.  van Bergen en  Henegouwen, W.  H.  Moolenaar,  and 
S. W. de I.aat.  1989. Signal transduction by epidermal growth factor oc- 
curs through the subclass of high-affinity receptors.  J.  Cell  Biol.  109: 
2495-2507. 
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